AG

Alby Gineesh

Active Director Director DIN 08522906
DIN 08522906 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Alby Gineesh

Data last updated:

Alby Gineesh is a Director at Cynoptic Medisystems Private Limited (since 2019). The company operates in Healthcare. Cynoptic Medisystems Private Limited reported revenue of ₹2.8 Lakh (FY 2020).

DIN 08522906
Primary Designation Director
Industry Healthcare
First Appointment 29 Jul 2019
Oldest Company Age 7 yrs
Largest company Cynoptic Medisystems Private Limited · ₹2.8 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cynoptic Medisystems Private Limited U85110KL2019PTC059012
Director29 Jul 20192019₹2.8 Lakh (FY 2020)Active

Board colleagues of Alby Gineesh

Directorship timeline

Open interactive timeline →
Cynoptic Medisystems Private Limited
Premium access

Shareholding and investment profile for Alby Gineesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alby Gineesh

Alby Gineesh currently holds 1 directorship: Cynoptic Medisystems Private Limited (Director, since 29 Jul 2019, revenue ₹2.8 Lakh (FY 2020)).

Alby Gineesh was first appointed on 29 Jul 2019 as Director at Cynoptic Medisystems Private Limited.

The current boards of Alby Gineesh's companies include Binish (Cynoptic Medisystems Private Limited), Rini Mary (Cynoptic Medisystems Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available